Changing patterns of coronary heart disease in the Hunter Region of New South Wales, Australia

Journal of Clinical Epidemiology

Volumn 52, Issue 8, 1999, Pages 761-771

  Dobson, Annette J ^a   McElduff, Patrick ^a   Heller, Richard ^a   Alexander, Hilary ^a   Colley, Paula ^a   D'Este, Kate ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Coronary death; Hospital treatment; Myocardial infarction; Primary prevention; Risk factors; Secondary prevention; WHO MONICA Project

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; AUSTRALIA; BLOOD PRESSURE; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MALE; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; SMOKING;

ADULT; AGE DISTRIBUTION; AGED; ASPIRIN; BLOOD PRESSURE; CORONARY DISEASE; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEW SOUTH WALES; PLATELET AGGREGATION INHIBITORS; POPULATION SURVEILLANCE; PRIMARY PREVENTION; RISK FACTORS; SMOKING CESSATION;

EID: 0033179551     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(99)00052-9     Document Type: Article

References (40)

1. Beaglehole R., LaRosa J.C., Heiss G., Davis C.E., Williams O.D., Tyroler H.A.et al. Serum cholesterol, diet, and the decline in coronary heart disease mortality. Prev Med. 8:1979;538-547.
2. Goldman L., Cook E.F. The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical intervention and changes in lifestyle. Ann Intern Med. 101:1984;825-836.
3. McGovern P.G., Pankow J.S., Shahar E., Doliszny K.M., Folsom A.R., Blackburn H.et al. Recent trends in acute coronary heart disease - mortality, morbidity, medical care, and risk factors. N Engl J Med. 334:1996;884-890.
4. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A., Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents Circulation. 90:1994;583-612.
5. Keil U., Kuulasmaa K. WHO MONICA Project. Risk factors Int J Epidemiol. 18(suppl 1):1989;S46-S55. [Erratum Int J Epidemiol 1990; 19: 776.].
6. Salomaa V., Dobson A., Miettinen H., Rajakangas A., Kuulasmaa K. Mild myocardial infarction - a classification problem in epidemiologic studies. J Clin Epidemiol. 50:1997;3-13.
7. Auckland Newcastle, Perth MONICA Centres Risk factor levels and mortality from ischaemic heart disease in three Australasian centres. Med J Aust. 148:1988;61-65.
8. Kinlay S., Dobson A.J., Heller R.F., Dickeson J.E., Ryan S. Lipid and apolipoprotein levels in an Australian community. Med J Aust. 154:1991;170-175.
9. Waterhouse J., Muir C., Correa P., Powell J. Cancer Incidence in Five Continents. 1976;International Agency for Research on Cancer, Lyon, France. IARC Scientific Publication no. 15.
10. Collett D. Modelling Binary Data. 1996;Chapman and Hall, London.
11. Dobson A., Filipiak B., Kuulasmaa K., Beaglehole R., Stewart A., Hobbs M.et al. Relations of changes in coronary disease rates and changes in risk factor levels. Methodological issues and a practical example Am J Epidemiol. 143:1996;1025-1034.
12. Neaton J.D., Wentworth D. Serum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease. Overall findings and differences by age for 316 099 white men. Arch Intern Med. 152:1992;56-64.
13. Law M.R., Wald N.J., Thompson S.G. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 308:1994;367-373.
14. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J.et al. Blood pressure, stroke and coronary heart disease. Part 1. Prolonged differences in blood pressure. prospective observational studies corrected for the regression dilution bias Lancet. 335:1990;765-774.
15. Manson J.E., Tosteson H., Ridker P.M., Satterfield S., Herbert P., O'Connor G.T.et al. The primary prevention of myocardial infarction. N Engl J Med. 326:1992;1406-1416.
16. Sturmans F., Mulder P.G.H., Valkenburg H.A. Estimation of the possible effect of interventive measures in the area of ischemic heart disease by the attributable risk percentage. Am J Epidemiol. 105:1977;281-289.
17. Antiplatelet Trialists' Collaboration Collaborative overview of randomised trials of antiplatelet therapy-I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ. 308:1994;81-106.
18. Teo K.K., Yusaf S., Furberg C.D. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomised controlled trials JAMA. 270:1993;1589-1595.
19. Fibrinolytic Therapy Trialists', (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction. Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Lancet. 343:1994;311-322.
20. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group ISIS-4. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 345:1995;669-685.
21. Ebrahim S., Smith G.D. Systematic review of randomised controlled trials of multiple risk factor in interventions for preventing coronary heart disease. BMJ. 314:1997;1666-1674.
22. Vartiainen E., Puska P., Pekkanen J., Toumilehto J., Jousilahti P. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ. 309:1994;23-27.
23. Sigfusson N., Sigvaldason H., Steingrimsdottir L., Gudmundsdottir I.I., Stefansdottir I., Thorsteinsson T.et al. Decline in ischaemic heart disease in Iceland and change in risk factor levels. BMJ. 302:1991;1371-1375.
24. ISIS-2 Collaborative Group Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. ISIS-2 Lancet. 2:1998;349-360.
25. Tverdal A., Thelle D., Stensvold I., Leren P., Bjartveit K. Mortality in relation to smoking history. 13 years' follow-up of 68,000 Norwegian men and women 35-49 years J Clin Epidemiol. 46:1993;475-487.
26. Collins R., Peto R., MacMahon S., Hebert P., Fiebach N.H., Eberlein K.A.et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure. Overview of randomised drug trials in their epidemiological context Lancet. 335:1990;827-838.
27. Dobson A.J., Evans A., Ferrario M., Kuulasmaa K.A., Moltchanov V.A., Sans S.et al. for the WHO MONICA Project). Changes in estimated coronary risk in the 1980s. Data from 38 populations in the WHO MONICA Project Ann Med. 30:1998;199-205.
28. Berns M.A.M., De Vries J.H.M., Katan M.B. Increase in body fatness as a major determinant of changes in serum total cholesterol and high density lipoprotein cholesterol in young men over a 10-year period. Am J Epidemiol. 130:1989;1109-1122.
29. Dobson A., Porteous J., McElduff P., Alexander H. Whose diet has changed? Aust N Z J Public Health. 21:1997;147-154.
30. Keil U., Liese A.D., Hense H.W., Filipiak B., Doring A., Stieber J.et al. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-92. Eur Heart J. 19:1998;1197-1207.
31. Bobak M., Skodova Z., Pisa Z., Poledne R., Marmot M. Political changes and trends in cardiovascular risk factors in the Czech Republic, 1985-92. J Epidemiol Community Health. 51:1997;272-277.
32. Wietlisbach V., Paccaud F., Rickenbach M., Gutzwiler F. Trends in cardiovascular risk factors (1984-1993) in a Swiss region. Results of three population surveys Prev Med. 26:1997;523-533.
33. Jackson R., Beaglehole R. Trends in dietary fat and cigarette smoking and the decline in coronary heart disease in New Zealand. Int J Epidemiol. 17:1987;377-382.
34. Ueshima H., Tatara K., Asakura S. Declining mortality from ischemic heart disease and changes in coronary risk factors in Japan, 1956-1980. Am J Epidemiol. 125:1987;62-72.
35. Hatano S. Changing CHD mortality and its causes in Japan during 1955-1995. Int J Epidemiol. 18:1989;S149-S158.
36. Dobson A.J. Trends in cardiovascular risk factors in Australia, 1966-1983. Evidence from prevalence surveys Community Health Studies. 11:1987;2-14.
37. Menotti A., Scanga M. Trends in coronary risk factors in Italy. Int J Epidemiol. 21:1992;883-892.
38. Dobson A.J. Relationship between risk factor trends and disease trends. Ann Med. 26:1994;67-71.
39. Hunink M.G.M., Goldman L., Tosteson A.N.A., Mittleman M.A., Goldman P.A., Williams L.W.et al. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA. 277:1997;535-542.
40. Rosamond W.D., Chambless L.E., Folsom A.R., Cooper L., Conwill D.E., Clegg L.et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med. 339:1998;861-867.